Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jac/dkv281PMID 26419763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The changing epidemiology of bacteraemic osteoarticular infections in the early 21st century.

  2015cited by this paper
• Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation.

  2014cited by this paper
• Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study.

  2014cited by this paper
• Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo.

  2014cited by this paper
• Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.

  2014cited by this paper
• [Colistin: a review].

  2014cited by this paper
• Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America.

  2013cited by this paper
• The MerR-Like Regulator BrlR Impairs Pseudomonas aeruginosa Biofilm Tolerance to Colistin by Repressing PhoPQ

  2013cited by this paper
• Difficult-to-treat Gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin.

  2013cited by this paper
• Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality

  2013cited by this paper
• Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.

  2013cited by this paper
• Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

  2012cited by this paper
• The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms.

  2012cited by this paper
• In Vivo Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection

  2012cited by this paper
• Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group

  2012cited by this paper
• Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?

  2012cited by this paper
• A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition

  2011cited by this paper
• Prosthetic joint infection: diagnosis and management

  2011cited by this paper
• Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

  2011cited by this paper
• Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model

  2011cited by this paper
• Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model

  2010cited by this paper
• High-Dose Continuous Infusion β-Lactam Antibiotics for the Treatment of Resistant Pseudomonas Aeruginosa Infections in Immunocompromised Patients

  2010cited by this paper
• Antibiotic resistance of bacterial biofilms.

  2010cited by this paper
• Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.

  2010cited by this paper
• Gram-negative prosthetic joint infections: risk factors and outcome of treatment.

  2009cited by this paper
• Continuous-Infusion β-Lactam Antibiotics During Continuous Venovenous Hemofiltration for the Treatment of Resistant Gram-Negative Bacteria

  2009cited by this paper
• Colistin in the 21st century

  2009cited by this paper
• Clinical practice. Infection associated with prosthetic joints.

  2009cited by this paper
• Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

  2009cited by this paper
• Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB‐oprM genes

  2008cited by this paper
• Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis

  2008cited by this paper
• Continuous infusion of β-lactam antibiotics in severe infections: a review of its role

  2007cited by this paper
• Management of a multidrug-resistant Pseudomonas aeruginosa infected total knee arthroplasty using colistin. A case report and review of the literature.

  2007cited by this paper
• Continuous infusion of beta-lactams

  2007cited by this paper
• Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.

  2007cited by this paper
• Diagnosis and treatment of infections associated with fracture-fixation devices.

  2006cited by this paper
• Differentiation and Distribution of Colistin- and Sodium Dodecyl Sulfate-Tolerant Cells in Pseudomonas aeruginosa Biofilms

  2006cited by this paper
• Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.

  2005cited by this paper
• Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

  2004cited by this paper
• Treatment of infections associated with surgical implants.

  2004cited by this paper
• Osteomyelitis.

  2004cited by this paper
• Prosthetic-joint infections.

  2004cited by this paper
• Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms

  2003cited by this paper
• Management of Infection Associated with Prosthetic Joints

  2003cited by this paper
• Interactions of Bacterial Cationic Peptide Antibiotics with Outer and Cytoplasmic Membranes ofPseudomonas aeruginosa

  2000cited by this paper
• Bacterial biofilms: a common cause of persistent infections.

  1999cited by this paper
• Prosthetic joint infection: when can prosthesis salvage be considered?

  1999cited by this paper
• Biofilms and beta-lactam activity.

  1998cited by this paper
• Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response

  1990cited by this paper

• 2025 ICM: Minimal Biofilm Eradication Concentration (MBEC) versus Minimum Inhibitory Concentration (MIC).

  2025cites this paper
• Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections

  2025cites this paper
• Degradable Hydrophilic Poly(ethylene glycol) Microspheres for the Sustained Delivery of Peptide-Based Antibiotics for Local Anti-infective Therapies.

  2025cites this paper
• Challenges and strategies in the treatment of periprosthetic joint infection caused by multidrug-resistant Gram-negative bacteria: a narrative review.

  2025cites this paper
• The comparison of three regimens of polymyxin B for the treatment of central nervous system infections caused by carbapenem-resistant bacteria: A retrospective cohort study.

  2025cites this paper
• Noncytotoxic polymyxin derivatives enhance antibiotic action against multidrug-resistant Gram-negative bacteria

  2025cites this paper
• 2025 ICM: Use of Newer Antibiotics and Fluoroquinolone-Resistance.

  2025cites this paper
• Phage Therapy for Bone and Joint Infections: A Comprehensive Exploration of Challenges, Dynamics, and Therapeutic Prospects.

  2024cites this paper
• Rapid bone destruction caused by multidrug-resistant Pseudomonas aeruginosa septic arthritis: A case report

  2024influential citation
• Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study

  2024cites this paper
• Outcomes After Pseudomonas Prosthetic Joint Infections

  2024influential citation
• Efficacy of meropenem extended infusion vs. intermittent bolus monotherapy and its combinations with colistin against Pseudomonas aeruginosa biofilm.

  2023cites this paper
• Sensitive and Direct Analysis of Pseudomonas aeruginosa through Self-Primer-Assisted Chain Extension and CRISPR-Cas12a-Based Color Reaction

  2023cites this paper
• A Case of ECMO-Assisted Heart Transplantation with Pulmonary Hypertension and Liver/Kidney Failure

  2023cites this paper
• Therapeutic Drug Monitoring of Vancomycin Concentrations for the Management of Bone and Joint Infections: An Urgent Need

  2023cites this paper
• Effectiveness and safety of colistin among older adults: a systematic review and meta-analysis.

  2022cites this paper
• Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study.

  2022influential citation
• Intermittent Short-Term Infusion vs. Continuous Infusion of Piperacillin: Steady State Concentrations in Porcine Cervical Spine Tissue Evaluated by Microdialysis

  2022cites this paper
• How to Manage Pseudomonas aeruginosa Infections.

  2022cites this paper
• Antibacterial activity potential of leaf extracts of Blepharis maderaspatensis and Ziziphus oenoplia against antibiotics resistant Pseudomonas strains isolated from pus specimens

  2022cites this paper
• Synergistic antibacterial and anti-biofilm activities of resveratrol and polymyxin B against multidrug-resistant Pseudomonas aeruginosa

  2022cites this paper
• The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant Pseudomonas aeruginosa in Clinical Settings

  2022cites this paper
• Establishment of a Novel Rat Model of Gram-Negative Periprosthetic Joint Infection Using Cementless Hip Hemiarthroplasty

  2022cites this paper
• Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?

  2021cites this paper
• Host-mediated susceptibility of Pseudomonas aeruginosa to azithromycin

  2021cites this paper
• Evaluation of Benzylpenicillin as an Internal Standard for Measurement of Piperacillin Bone Concentrations via Microdialysis.

  2021cites this paper
• Rescuing the Last-Line Polymyxins: Achievements and Challenges

  2021cites this paper
• Methods for Bioaerosol Characterization

  2020cites this paper
• Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes?

  2020cites this paper
• Polymyxin Delivery Systems: Recent Advances and Challenges

  2020cites this paper
• Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study

  2020influential citation
• Methods for Bioaerosol Characterization: Limits and Perspectives for Human Health Risk Assessment in Organic Waste Treatment

  2020cites this paper
• Infección de prótesis articular por Pseudomonas stutzeri: Reto terapéutico asociado a múltiples graves complicaciones

  2020cites this paper
• Difficult-to-treat pathogens significantly reduce infection resolution in periprosthetic joint infections.

  2020cites this paper
• In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion and its combination with colistin against Pseudomonas aeruginosa biofilm.

  2020cites this paper
• Review of the international consensus guidelines for the optimal use of the polymyxins

  2019cites this paper
• Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.

  2019cites this paper
• Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction

  2019cites this paper
• Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.

  2019cites this paper
• Measurement of ceftolozane and tazobactam concentrations in plasma by UHPLC-MS/MS. Clinical application in the management of difficult-to-treat osteoarticular infections.

  2019cites this paper
• [Chinese expert consensus on polymyxins in the clinical practice].

  2019cites this paper
• General Assembly, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic Infections.

  2019cites this paper
• Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic Review and Meta-Analysis

  2019cites this paper
• Do bacteriophages have a role in treating multidrug-resistant periprosthetic joint infection ( PJI ) ?

  2019cites this paper
• Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa

  2019cites this paper
• Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections

  2019influential citation
• Hip and Knee Section, Treatment, Debridement and Retention of Implant: Proceedings of International Consensus on Orthopedic Infections.

  2019cites this paper
• Antimicrobial treatment in bone and joint infections

  2019cites this paper
• A new multifunctionalized material against multi‐drug resistant bacteria and abnormal osteoclast activity

  2018cites this paper
• PART XI.indd

  2018cites this paper
• choice and duration of antibiotic therapy in polymicrobial surgical site infection / periprosthetic joint infection ( SSI / PJI ) ?

  2018cites this paper
• Антибактериальная активность покрытий на основе импрегнированного антибиотиками костного цемента в отношении микроорганизмов с различными уровнями антибиотикорезистентности

  2018cites this paper
• Management of Periprosthetic Joint Infection

  2018cites this paper
• Beta-lactams in continuous infusion for Gram-negative bacilli osteoarticular infections: an easy method for clinical use

  2018cites this paper
• Antibacterial Activity of Antibiotic-Impregnated Bone Cement Based Coatings Against Microorganisms with Different Antibiotic Resistance Levels

  2018cites this paper
• Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1

  2017cites this paper
• Combination therapy for extensively-drug resistant gram-negative bacteria

  2017cites this paper
• Colistin loading dose enhanced antimicrobial activity for in vivo mouse thigh infection model with Pseudomonas aeruginosa with highly antimicrobial resistant.

  2017cites this paper